Featured Biotech ETFs Stable Despite Disappointing Treatment Date From Gilead By Ian YoungApril 23, 2020
Multi-Asset Content Hub With Mortgage-Backed Securities, Discipline Matters By Tom LydonApril 22, 2020
Disruptive Technology Content Hub 2 Biotechnology ETFs That Could Be Good For Diversification By Ian YoungMarch 26, 2020
Disruptive Technology Content Hub Biotech ETFs Are Not Riding the Wave from Coronavirus Panic By Max ChenJanuary 24, 2020
Investing Biotech ETFs Slip as Trump Administration Pushes for Cheap Drug Imports By Max ChenDecember 18, 2019
Thematic Investing Content Hub Investors Are Moving Back Into Resurgent Biotech ETFs By Tom LydonDecember 9, 2019
Thematic Investing Content Hub Biotech ETF Rally Not Yet Luring Investors By Tom LydonNovember 25, 2019
Thematic Investing Content Hub It Could be to Time to Bank on Biotech ETFs By Tom LydonOctober 21, 2019
Beyond Basic Beta Content Hub Biotech ETFs Had A Rough Third Quarter By Todd ShriberSeptember 30, 2019
Innovative ETFs Content Hub Drug Pricing Reforms Keep Pressure on Biotech, Healthcare ETFs By Max ChenSeptember 26, 2019
Featured Health Concerns Over Vaping Escalate As Walmart Pulls E-Cigarettes From Shelves By Ian YoungSeptember 24, 2019
Innovative ETFs Content Hub ACADIA Pharmaceuticals Help Lift Biotech ETFs By Max ChenSeptember 9, 2019
